Ubong Peters
11PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.Dejan Juric, Kyung Song, Radia M Johnson
|Sep 05, 2024
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard
|Jan 05, 2023
Lung de-recruitment in the allergic asthma of obesity: evidence from an anatomically based inverse model.Jason H T Bates, David A Kaminsky, Olivia J Garrow
|Oct 14, 2022
Considerations for Embedding Inclusive Research Principles in the Design and Execution of Clinical Trials.Ubong Peters, Brenna Turner, Daniel Alvarez
|Oct 14, 2021
Positive expiratory pressure: a potential therapy to mitigate acute bronchoconstriction in the asthma of obesity.Swati A Bhatawadekar, Anne E Dixon, Ubong Peters
|Jan 06, 2021
Central airway collapse is related to obesity independent of asthma phenotype.Swati A Bhatawadekar, Ubong Peters, Ryan R Walsh
Pageof 2
Frequent Collaborators
4 joint publications
Jason H T Bates
2 joint publications
Swati Bhatawadekar
2 joint publications
Kevin Kalinsky
2 joint publications
Antoine Italiano
2 joint publications
Komal L Jhaveri
2 joint publications
Melissa K Accordino
2 joint publications
Philippe L Bedard
2 joint publications
Andrés Cervantes
2 joint publications
Valentina Gambardella
2 joint publications
Erika Hamilton
